Small molecule · developed by Lakefront Biotherapeutics NV
GLPG0492 is an oral drug studied in a clinical trial in healthy volunteers, tested as an oral solution and as a capsule formulation under fasting and high-fat meal conditions.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT01130818 | Phase 1 | Healthy | Completed | LKFT |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Healthy
Updated Oct 18, 2026. Something wrong or missing? Report it on the LKFT page.
See LKFT's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
LKFT catalysts and pipeline →